The University of Chicago Header Logo

Connection

Olatoyosi Odenike to CD40 Antigens

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about CD40 Antigens.
Olatoyosi Odenike
Connection Strength
0.103
CD40 Antigens
  1. Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia. Leuk Lymphoma. 2012 Nov; 53(11):2136-42.
    View in: PubMed
    Score: 0.103
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.